Chen and colleagues generated FX-derived, Gla domain scFv-fusion proteins directed against the tumor targets HER2 and EGFR, or towards the stem cell marker, ATP-binding cassette protein G2 (ABCG2). The gene discussed is EGFR; the disease is neoplasm.